Search...
Roth MKM Remains a Buy on GeoVax Labs (GOVX)
I'm PortAI, I can summarize articles.
Roth MKM's Jonathan Aschoff maintains a Buy rating on GeoVax Labs with a $14.00 price target. Aschoff, who covers the Healthcare sector, has an average return of -18.3% and a 30.59% success rate. GeoVax Labs holds a Moderate Buy consensus among analysts, with a price target consensus of $14.00.
In a report released today, Jonathan Aschoff from Roth MKM maintained a Buy rating on GeoVax Labs, with a price target of $14.00.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
According to TipRanks, Aschoff is an analyst with an average return of -18.3% and a 30.59% success rate. Aschoff covers the Healthcare sector, focusing on stocks such as Biofrontera, GeoVax Labs, and Moleculin Biotech.
GeoVax Labs has an analyst consensus of Moderate Buy, with a price target consensus of $14.00.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments